FIELD: medicine. SUBSTANCE: method involves producing cell suspension from an embryo taken at fetus stage of development of genetically homogeneous animals, carrying out multiple immunization of animals of the same genetic line using the suspension, taking spleen cells, separating lymphocytes, immunizing animals of the same genetic line with the lymphocytes suspension and producing the antiserum to be added to physiological fluids of a testee. Results reliably differing from the control being obtained, tumor case is to be diagnosed. EFFECT: enhanced sensitivity and applicability of the method. 4 cl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF DIAGNOSING MALIGNANT TUMORS UTILIZING COMMON TUMOR ANTIGEN-SPECIFIC ANTISERUM | 1998 |
|
RU2137136C1 |
METHOD FOR DIAGNOSING TUMORS | 2004 |
|
RU2277242C2 |
METHOD OF MALIGNANT TUMOR DIAGNOSIS | 1995 |
|
RU2111495C1 |
METHOD OF TUMORЪS DIAGNOSTIC | 0 |
|
SU1836640A3 |
METHOD OF MALIGNANT TUMOR DIAGNOSIS | 1993 |
|
RU2082981C1 |
METHOD FOR OBTAINING ANTIIDIOTYPICAL SERUM FOR PREDICTING MALIGNANT TUMORS | 2000 |
|
RU2205410C2 |
DIFFERENTIAL DIAGNOSIS METHOD FOR DETERMINING NEOPLASTIC FORMATIONS IN LUNG | 1992 |
|
RU2051385C1 |
PHARMACEUTICAL COMPOSITION FOR INDUCING OF IMMUNE RESPONSE IN HUMAN | 2002 |
|
RU2313365C2 |
PROTEIN-PEPTIDE ANTITUMOR COMPOSITION, CELL PREPARATION ACTIVATED THEREWITH AND METHOD FOR TUMOR PROPHYLAXIS OR TREATMENT | 2004 |
|
RU2283129C1 |
COMPOSITIONS AND METHODS FOR WT1-SPECIFIC IMMUNOTHERAPY | 1999 |
|
RU2237674C2 |
Authors
Dates
2000-05-20—Published
1998-04-20—Filed